Trademark: 79364021
Word
SEPSIA THERAPEUTICS
Status
Pending
Status Code
641
Status Date
Sunday, February 25, 2024
Serial Number
79364021
Mark Type
3000
Filing Date
Wednesday, October 26, 2022

Trademark Owner History

Classifications
5 House mark for pharmaceutical products namely, pharmaceutical preparations for human use; house mark for biological preparations for medical and veterinary use, namely, biological preparations for the treatment of diseases; pharmaceutical, biological and veterinary preparations for the treatment of infectious diseases and related inflammatory processes, for the treatment of sepsis and for advanced cell therapies and immunotherapy; pharmaceutical preparations containing nucleic acids and/or proteins and active peptides for medical and veterinary use, namely, pharmaceutical preparations containing nucleic acids and/or proteins and active peptides for the treatment of infectious diseases and related inflammatory processes, for the treatment of sepsis and for advanced cell therapies and immunotherapy
10 House mark for medical and veterinary apparatus and instruments, namely, surgical and medical instruments; medical and veterinary apparatus, devices and instruments for the treatment of infectious diseases and associated inflammatory processes, for the treatment of sepsis, and for advanced cell therapies and immunotherapy; medical devices for dialysis, hemoperfusion and hemoadsorption; medical devices for blood purification; medical adsorption devices and polymeric adsorption materials for the removal of materials from the blood or from blood fractions and kits containing said testing devices for the identification of bacteria for medical use; electrical instruments for medical use in blood diagnostics; assay instruments for medical diagnostic use in measuring, testing and analyzing blood, body fluids, cells, proteins, peptides and nucleic acids infectious diseases and associated inflammatory processes, sepsis and in advanced cell therapies and immunotherapy; medical diagnostic testing instruments for use in immunoassay procedures; diagnostic apparatus for medical use in measuring, testing and analyzing blood, body fluids, cells, proteins, peptides and nucleic acids infectious diseases and associated inflammatory processes, sepsis and in advanced cell therapies and immunotherapy; medical diagnostic testing apparatus for use in measuring, testing and analyzing blood, body fluids, cells, proteins, peptides and nucleic acids immunoassay procedures; apparatus and instruments for diagnostic testing for medical purposes in measuring, testing and analyzing blood, body fluids, cells, proteins, peptides and nucleic acids infectious diseases and associated inflammatory processes, sepsis and in advanced cell therapies and immunotherapy; apparatus and instruments for veterinary diagnosis in measuring, testing and analyzing blood, body fluids, cells, proteins, peptides and nucleic acids infectious diseases and associated inflammatory processes, sepsis and in advanced cell therapies and immunotherapy; medical diagnostic instruments for diagnosis in measuring, testing and analyzing blood, body fluids, cells, proteins, peptides and nucleic acids infectious diseases and associated inflammatory processes, sepsis and in advanced cell therapies and immunotherapy; dialysis apparatus, namely, dialysis and hemofiltration machines; dialysis machines for veterinary use, namely, dialysis and hemofiltration machines ; dialysis machines for medical use
42 Scientific and technological services, as well as associated research and design services, namely, scientific research and development; industrial analysis services related to biology, biochemistry, chemistry, pharmacy, medicine and veterinary medicine , industrial research in the fields of biology, biochemistry, chemistry, pharmacy, medicine and veterinary medicine; scientific research services related to biology, biochemistry, chemistry, pharmacy, medicine and veterinary medicine; scientific research services related to the treatment of infectious diseases and related inflammatory processes, sepsis and advanced cell therapies and immunotherapy; scientific research services related to peptides and proteins for pharmaceutical, medical and veterinary use
The mark consists of the word "SEPSIA" in stylized capital letters, where the term "SEP" is in blue, and the term "SIA" on a blue background in the form of a halved oblong shape. Below in stylized lowercase letters in blue is the wording "THERAPEUTICS". The color white represents background and is not a part of the mark.
The color(s) blue is/are claimed as a feature of the mark.
The English translation of "SEPSIA" in the mark is "Sepsis".
"THERAPEUTICS"

Trademark Events
Mar 26, 2024
Refusal Processed By Ib
Feb 25, 2024
Notification Of Non-Final Action E-Mailed
Feb 25, 2024
Non-Final Action E-Mailed
Feb 25, 2024
Non-Final Action Written
Jan 25, 2024
Teas/Email Correspondence Entered
Jan 24, 2024
Correspondence Received In Law Office
Jan 24, 2024
Teas Response To Office Action Received
Oct 4, 2023
Refusal Processed By Ib
Sep 11, 2023
Non-Final Action Mailed - Refusal Sent To Ib
Sep 11, 2023
Refusal Processed By Mpu
Aug 19, 2023
Non-Final Action (Ib Refusal) Prepared For Review
Aug 18, 2023
Non-Final Action Written
Aug 10, 2023
Assigned To Examiner
Mar 7, 2023
Application Filing Receipt Mailed
Mar 3, 2023
New Application Office Supplied Data Entered
Mar 2, 2023
Sn Assigned For Sect 66a Appl From Ib

Trademark Alertz updated from USPTO on 2030-01-24